GlaxoSmithKline Consumer Nigeria Plc reports a loss of N238.07 million in Q1 2021.

GlaxoSmithKline Consumer Nigeria Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue for the period was N3.5 billion. (-30.6% YoY)
  • Cost of sales was N2.4 billion. (-30.6% YoY)
  • Administrative expenses totalled N502.96 million. (+0.3% YoY)
  • Loss for the period was N238.07 million
  • Loss per share from continuing operations was 20 kobo.

See link to results.

Leave a Reply

Your email address will not be published. Required fields are marked *